This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...
GRAND RAPIDS, Mich. (ABC 4)- There is a new member of the Corewell Health Helen DeVos Children’s Hospital team, and she’s pretty paw-some! Meet Indi, the hospital’s first facility dog, trained through ...